+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmacyclics llc - logo

Pharmacyclics LLC focuses on developing novel therapies for the treatment of cancer and immune-mediated diseases in the United States. The company markets IMBRUVICA, a single-agent therapy used for the treatment of patients with chronic lymphocytic leukemia, mantle cell lymphoma and waldenström's macroglobulinemia. It also has several product candidates in clinical development. The company was founded in 1991 and is headquartered in Sunnyvale, California.

From
B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2020 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
From
From
Pharmacyclics LLC - Strategic SWOT Analysis Review - Product Thumbnail Image

Pharmacyclics LLC - Strategic SWOT Analysis Review

  • SWOT Analysis
  • August 2022
  • 23 Pages
From
Loading Indicator